The Distancer is a simple, handheld device that aims to help ensure the safety of key workers. None of us are enjoying the loss of self-determination that this invisible enemy has brought into our lives. The feeling of helplessness just…
In a perspective piece published in the journal Science, UC San Diego experts describe in detail the growing evidence that SARS-CoV-2, the novel coronavirus that causes COVID-19, can be spread by asymptomatic people via aerosols – a reality that deeply…
The pharmaceutical industry is leading the charge in vaccine and drug development, while simultaneously modifying existing trials to the new environment, and keeping their staff and patients safe. But the industry will be different after the crisis passes, and sponsors…
Within days of social media companies taking down a viral video touting conspiracy theories about the novel coronavirus, a clip popped up on YouTube telling viewers about another way they could still access the banned footage: through a link to…
In the past decade or so, artificial intelligence has gone from the pages of science fiction novels to a very real power that has disrupted — or threatens to disrupt — nearly every process on earth. AI helps our cars,…
[fusion_builder_container hundred_percent=”no” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” class=”” id=”” background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” parallax_speed=”0.3″ video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” overlay_color=”” video_preview_image=”” border_color=”” border_style=”solid” padding_top=”” padding_bottom=”” padding_left=”” padding_right=”” type=”legacy”][fusion_builder_row][fusion_builder_column type=”1_1″ layout=”1_1″ background_position=”left top” background_color=”” border_color=”” border_style=”solid” border_position=”all” spacing=”yes”…
As more trials take place and new emerging therapies are publicised, drug companies will now be under pressure to show their own compassion regarding drug development royalties. Moreover, in a time of economic regression and global health fears due to…
Some companies are repurposing or developing treatment, others are focusing on vaccines, tests or technology to deliver drugs in the body. Existing drugs being repurposed Gilead Sciences Inc’s (NASDAQ:GILD) antiviral medication remdesivir is undergoing the final phase of clinical trials,…
‘I think the critical piece to making it work is to build trust between leadership and the team, and the team with each other,’ says Wildbit co-founder and CEO Natalie Nagele. (Bernadett Szabo/Reuters) Working from home may be a steep…
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, orange, emerging from the surface of cells, gray, cultured in the lab. File photo/AP, NIAID-RML Researchers in the…
Like it or not, artificial intelligence (AI) has already begun to reshape the way pharma and biotech companies operate at almost every level. The integration of AI-based data analysis into the entire spectrum of these companies’ activities has led to…
The number of clinical research programs undertaken by the major pharma players has now fallen by as much as 70% in the last ten years. The global pharmaceutical industry has spent well over a trillion dollars on research and development…
NASA’s TRISH has funded innovative projects seeking to better protect astronauts’ health during deep space missions. Two of the six projects focus on ‘just-in-time’ medications, which allow drugs to be manufactured on-demand and onboard the spacecraft. Allie Nawrat talks to…
There is an increasing need to quickly publish emerging clinical evidence supporting novel treatments and medications and extend the reach of key medical claims to new target audiences. pharma digital publication planning It’s estimated $58.8 billion USD is invested every…
The rapid growth of patient centricity over the last few years and considers what pharma’s next steps should be to enhance patient engagement. I still consider myself a relative newbie to the pharma industry, having only started seriously covering the…
